Medetomidine veterinary sedative increasingly found in fentanyl supplies

Researchers at the Perelman School of Medicine at the University of Pennsylvania have identified an increasing presence of medetomidine, a powerful veterinary sedative, within illicit fentanyl supplies. A study published in JAMA Internal Medicine indicates that cases of severe withdrawal related to this substance have quadrupled in recent years.

Medetomidine, used as an anesthetic for large animals, is reportedly 100 to 200 times more potent than xylazine. Withdrawal symptoms can manifest rapidly and include tachycardia, extreme anxiety, nausea, vomiting, and potential organ damage.

Due to the complexity of treating these symptoms, patients often require intensive care unit (ICU) stays and specialized infused medications, such as dexmedetomidine, to manage risks like low heart rate and blood pressure. Medical professionals noted that the emergence of this drug requires hospitals and public health officials to adapt treatment protocols and resource allocation.